Abstract Voltage-gated calcium (Ca v ) channels and protein kinase C (PKC) isozymes are involved in insulin secretion. In addition, Ca v b, one of the auxiliary subunits of Ca v channels, also regulates the secretion of insulin as knockout of Ca v b3 (b3 -/-) subunits in mice led to efficient glucose homeostasis and increased insulin levels. We examined whether other types of Ca v b subunits also have similar properties. In this regard, we used small interfering RNA (siRNA) of these subunits (20 lg each) to downregulate them and examined blood glucose, serum insulin and PKC translocation in isolated pancreatic b cells of mice. While the down-regulation of Ca v b2 and b3 subunits increased serum insulin levels and caused efficient glucose homeostasis, the down-regulation of Ca v b1 and b4 subunits failed to affect both these parameters. Examination of PKC isozymes in the pancreatic b-cells of Ca v b2-or b3 siRNAinjected mice showed that three PKC isozymes, viz., PKC a, bII and h, translocated to the membrane. This suggests that when present, Ca v b2 and b3 subunits inhibited PKC activation. Among these three isozymes, only PKCa siR-NA inhibited insulin and increased glucose concentrations. It is possible that the activation of PKCs bII and h is not sufficient for the release of insulin and PKCa is the mediator of insulin secretion under the control of Ca v b subunits. Since Ca v b subunits are present intracellularly, it is possible that they (1) inhibited the translocation of PKC isozymes to the membrane and (2) decreased the interaction between Ca v channels and PKC isozymes and thus the secretion of insulin.
Introduction
Glucose is the major stimulant for the secretion of insulin from the b-cells of the pancreas. Following its entry into the cells, it is metabolized to ATP leading to the increase of ATP-to-ADP ratio. As a consequence, ATP-sensitive K ? channels close, cell membranes depolarize and the high voltage-gated calcium (Ca v ) channels open. The subsequent entry of Ca 2? into the cells increases intracellular Ca 2? ([Ca 2? ] i ), activates protein kinase C (PKC) isozymes and releases insulin [1] [2] [3] [4] . In addition, glucose also activates PKC directly leading to the insulin release [5, 6] .
The family of PKC consists of 11 isozymes and grouped under three subfamilies, viz., classic PKCs (a, bI, bII and c), novel PKCs (d, e, g and h) and atypical PKCs (f, i/k and l), based on cofactor requirements [7] . PKCs a and e are dominant in the pancreatic islet b-cells and translocate to membrane by the stimulation with glucose [5, [8] [9] [10] . The contribution of other PKC isozymes cannot be ruled out as PKCs bII, c, h, k and f also were translocated to membrane with glucose or potassium-induced stimulation of insulin secretion [6, 10, 11] .
Ca v channels are a family of hetero-multimers classified into ten types (Ca v 1.1, 1.2, 1.3, 1.4; 2.1, 2.2, 2.3 and 3.1, 3.2, 3.3) based on their major and the pore-forming a 1 subunits. In addition to this, there are two to three minor or auxiliary subunits, viz., b, a 2 /d and c, that modulate the channel expression and current kinetics [12, 13] . While Ca v 1.2 and 1.3 type channels play a major role in the release of insulin, other types of Ca v channels also contribute to this process to a certain extent [14] [15] [16] [17] [18] [19] . These channels interact with the PKC isozymes and that subsequently lead to the exocytosis of insulin [20] [21] [22] . The interaction between these two proteins is made possible as PKC isozymes target the serine/threonine (Ser/Thr) sites of Ca v a 1 subunits leading to the potentiation of the Ca v currents (I Ca ) [23] [24] [25] [26] [27] [28] .
In spite of the interaction between the Ca v a 1 subunits and the PKC isozymes in the insulin release, Ca v b subunits also modulate insulin secretion. Recently, in a classic study, increased insulin release and glucose homeostasis were observed in Ca v b3 knockout (b3 -/-) mice [29] . It is not known whether these activities are applicable to Ca v b2, another Ca v b subunit present in the pancreas [4, [29] [30] [31] [32] among the four (b1 to b4) Ca v b subunits known. It is one of our aims to examine the effects of Ca v b2 subunit on insulin release and glucose homeostasis.
The increased insulin secretion and glucose homeostasis in b3 -/-mice were accompanied with enhanced inositol triphosphate (IP3), mobilization of [Ca 2? ] i and Ca 2? oscillation frequency [29] . Hence, when present, these components, along with insulin release, may have been inhibited by the Ca v b3 subunit, a process called negative modulation. The negative modulation of IP3 and [Ca 2? ] i may have inhibited the activation of PKC [7, 33] , and subsequently, insulin release as PKC is a known secretagogue for insulin [2, 20] . However, it is not clear which PKC isozymes are involved in this process. Hence, our second aim in this study is to identify the PKC isozymes involved in the negative modulation of insulin release by the Ca v b subunits. In this regard, we employed small interfering RNA (siRNA) to down-regulate Ca v b subunits and studied the blood glucose, serum insulin and PKC translocation in isolated pancreatic b cells of mice.
Materials

Animals
Adult male ICR mice (25-30 g; Harlan Laboratories, Inc., USA) were used for all the studies. They were housed at a constant temperature of 22-23°C with 12-h light/dark cycle and ad libitum access to food and water unless otherwise indicated. All animal experiments were conducted at Old Dominion University, Norfolk, Virginia, following the stipulations set by their Institute Animal Care and Use Committee (IACUC). 0 . The siRNA aliquots were stored at -20°C in a final concentration of 100 lM. They were used at a concentration of 20 lg/mice by suspending in 1 ml of normal saline; this was injected rapidly ('highpressure' injection;\5 s) into the tail vein of the mice. The mice were used 24 h post injection for (1) GTT, (2) isolation of pancreatic islets and insulin determination, (3) islet cell culture, siRNA transfection, insulin determination and immunocytochemistry and (4) Western blotting.
GTT
The mice were deprived of food for 12-14 h before the GTT, but had free access to water. The GTT was initiated with the injection of D-glucose (2 mg/g body weight, i.p.). The blood for GTT and insulin determination was taken at 0 min (before glucose injection) and 15, 30 and 60 min (after the administration of glucose) from the tail veins of these mice. The glucose concentration was determined using the Glucometer Elite (Bayer Corp., Diagnostics Gmbh, Leverkusen, Germany) and insulin by ELISA (Mouse Ultra-sensitive Insulin Immunoassay Kit, Alpco Diagnostics, Inc., Salem, NH, USA) following the protocol given by the supplier.
Isolation of pancreatic islets and insulin determination
The mouse was euthanized according to a protocol approved by the IACUC of Old Dominion University. The pancreatic islets were isolated following the method published [34] . They were incubated at 37°C overnight to allow them to recover from the collagenase treatment before the beginning of any experiment.
Three size-matched islets per group were manually selected, incubated in Krebs-Ringer solution and stimulated at 37°C with glucose (16.7 mM) in a volume of 1 ml for 1 h. The islets were then collected by centrifugation, and the supernatant was assayed for insulin content as described above.
Islet cell culture, siRNA transfection, insulin determination and immunocytochemistry Islet cell cultures obtained from naïve mice as described before [34] were used to transfect with siRNA and study insulin secretion. The islet cell suspension containing approximately 20,000 cells was seeded in Petri dishes containing cover slips coated with polylysine (0.5 mg/ml; Sigma). The cultures were used for the transfection with the siRNA and cDNA following the protocol given by the supplier (Reverse transfection; Lipofectamine RNAiMAX, Invitrogen, Carlsbad, CA, USA) after 24 h. The combinations for the transfection were (1) scrambled or Ca v b subunit siRNA (5 lg/dish), (2) Ca v b subunit siRNA (2.5 lg) and the PKC isozyme cDNA (2.5 lg) subcloned into green fluorescent protein (GFP) containing vector or (3) selected PKC isozyme siRNA (2.5 lg) and PKC isozyme cDNA (2.5 lg) subcloned into GFP containing vector.
Insulin release was studied approximately 48 h after the transfection by exposing the cells to 16.7 mM glucose for 1 h. The supernatant from the dishes was assayed for insulin content by ELISA as described above.
Translocation of PKC isozymes was studied in cultured pancreatic islet cells of mice by immunocytochemistry using a Carl Zeiss AG 510 LSM confocal microscope and a 9 100 plan-apochromat 9 100/1.4 oil objective. After the fixation of the cells with 4 % paraformaldehyde and permeabilization with 0.1 % Triton-X-100, the cells were incubated with rabbit polyclonal antibodies for specific PKC isozymes (Santa Cruz, CA, USA), diluted in 10 % serum/19 PBS (1:100) for overnight at 4°C. Cover slips were washed three times in 1 % serum for 5 min each, incubated for 1 h with 1:2,000 dilution of Alexa Fluor 488 goat anti-rabbit IgG (Invitrogen) diluted in 10 % serum/19 PBS. The excitation was measured by multi-track mode using the 543-and 633-nM lines of the HeNe lasers, and the emitted light was collected using [560-and [650-nM long-pass filters, respectively.
Western blotting of the pancreatic islets
The silencing of the Ca v b subunits by the siRNA was studied by Western blotting. The islets were pooled (*500 in each group) and equilibrated with 150 ll of homogenization buffer [in mM: EGTA 2, EDTA 2 and Tris-HCl 20 (pH 7.4), 2-mercaptoethanol 10 and protease inhibitors (1 mM phenyl-methylsulfonyl fluoride, 0.3 lM aprotinin and leupeptin (20 lg/ml)] and sonicated. The cytosolic (supernatant) and membrane (pellet) fractions were prepared by centrifugation at 100,0009g for 1 h at 4°C. The pellet was resuspended (150 ll) in the homogenization buffer containing 0.1 % triton 9 -100. Protein fractions (100 lg/lane) were analyzed on SDS/polyacrylamide gel with a Laemmli buffer system and transferred to nitrocellulose membrane. Immunodetection of Ca v b subunit proteins was performed with specific polyclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA and EMD Biosciences Inc., Darmstadt, Germany). The proteins were identified with ECL detection kit (Amersham Life Sciences, Buckinghamshire, UK) as instructed by the manufacturer.
Results
We employed siRNA for the down-regulation of the Ca v b subunits. The siRNA was injected through the tail vein by high pressure (meaning the shortest possible time), a method known to increase the potency of the genetic material. The rapid injection of unmodified genetic material into the tail vein, in a large volume, has been successfully used by several laboratories to deliver plasmid DNA [35, 36] or RNA [37] [38] [39] . According to Song et al. [38] , the target protein was reduced nearly to the background and the effect persisted for 10 days (with 3 consecutive daily injections). The study by Lewis et al. [37] showed that the expression of firefly luciferase was downregulated by 80-90 % 24 h after the injection of siRNAluc ? . Hamar et al. [39] identified a reduction of Fas mRNA by 74 ± 8 % in 24 h after the injection of Fas siRNA. Similarly, in this study, also both Ca v b2 and b3 subunits were down-regulated by the respective siRNAs as shown in the Western blotting (Fig. 1) . However, both Ca v b1 and b4 subunits were absent even in the control, suggesting that these two Ca v b subunits are not present in the pancreatic islets. The absence of Ca v b1 and b4 subunits reflected in the glucose tolerance test (GTT) as both blood glucose and serum insulin levels were not altered with the injection of the siRNA of either of these two subunits (Fig. 1) . In contrast, blood glucose levels were decreased and serum insulin concentration increased in the groups injected with the siRNA for Ca v b2 or Ca v b3 subunits. It is significant that in both these groups, fasting blood glucose or insulin levels were not affected. The changes seen in the insulin levels of intact animals with Ca v b subunit siRNA were reproduced by the in vitro studies also. Stimulation of the isolated islets from the Ca v b1 siRNA-injected mice with 16.7 mM glucose did not increase insulin levels (Fig. 2a) . In contrast, insulin levels were increased by the above concentration of glucose from the islets of Ca v b2 or b3 subunit siRNA-injected mice. In these studies also, the basal insulin levels were not increased. These results were reproduced in the cultured pancreatic b-cells transfected with the siRNA. While Ca v b1 siRNA-transfected cells failed to show any increase in the insulin, Ca v b2 or b3 siRNA transfected cells showed increase in the insulin level with the stimulatory concentration of glucose (Fig. 2b) .
Based on the role of Ca v b2 and b3 subunits in the increased glucose homeostasis and insulin levels, we studied the translocation of PKC isozymes to examine whether they are involved in this process in the miceadministered Ca v b2 or b3 siRNA. Confocal microscopy of the cultured b cells was conducted employing pGFP-tagged PKC isozymes. Of the 11 isozymes (PKCs a, bI, bII, c, d , e, g, h, f, i/k and l) that we examined, only PKCs a, bII and h were translocated to the membrane by either Ca v b2 or b3 siRNA as indicated by the intensity of the membrane in Fig. 3 .
The role of PKCs a, bII and h was followed up by studying their involvement in the insulin release and glucose homeostasis. In this regard, instead of activating these isozymes (and studying the possibly increased insulin and decreased glucose levels), we opted for their down-regulation with siRNA and studying the likelihood of decreased insulin and increased glucose levels by GTT. Surprisingly .001 compared to respective scrambled siRNA using t test; n = 4-7. CF cytoplasmic fraction, MF membrane fraction, scr. scrambled .001 compared to respective scrambled siRNA using t test; n = 3. scr. Scrambled of the three siRNAs that we examined, only PKCa siRNA decreased insulin concentration and increased blood glucose level and both PKC bII and h siRNAs failed to affect these two parameters (Fig. 4) . Subsequently, the efficacy of the PKC a, bII and h siRNAs to down-regulate these PKC isozymes was determined by confocal microscopy (Fig. 5) . .01 compared to respective scrambled siRNA using t test; n = 3. scr. Scrambled Fig. 5 Confocal microscopy of cultured pancreatic islet cells showing the down-regulation of PKC isozymes. Cultured pancreatic islet cells from the naive mice were cotransfected with scrambled or PKC a, bII or h siRNA and PKC a, c or e cDNA (top panel), PKC bII, c or h cDNA (middle panel) and PKC h, e or bII cDNA (bottom panel).
The cDNA for PKC isozymes is subcloned into GFP containing vector. A total of 2.5 lg each of PKC isozyme siRNA and PKC isozyme cDNA was used for the cotransfection. The cotransfection and immunohistochemistry were conducted as described under the methods. Bar 10 lM. scr. Scrambled
The siRNAs that we employed specifically down-regulated the isozymes intended and not the isozymes of the other selected PKC subtypes. To be specific, PKCa siRNA down-regulated PKCa isozyme, but not PKCc or e; PKCbII siRNA down-regulated PKCbII isozyme and not PKCs c and h; PKCh siRNA down-regulated PKCh and did not cross-react with PKCs bII and e (Fig. 5) . [4, 40] . Among these, Ca v 1.0 subfamily of channels is responsible for 60-80 % of glucose-stimulated insulin secretion [4, 40] . The remaining 20-40 % of insulin secretion is under the control of Ca v 2.0 family of channels, though the contribution by the Ca v 2.2 type of channels is doubtful [14] [15] [16] [17] [18] [19] 41] .
Discussion
In addition to the Ca v channels as such, Ca v b subunits also modulated the secretion of insulin as there was increased insulin and efficient glucose homeostasis in b3 -/-mice [29] . The effects seen in b3 -/-mice were reproduced by the down-regulation of the b3 subunits with the siRNA in this study (Fig. 1) . The negative modulation of insulin secretion by the Ca v b3 subunits was shared by the Ca v b2 subunits, the only other Ca v b subunit presents in the pancreas [4, [29] [30] [31] [32] . The modulation of insulin secretion by the Ca v b2 and b3 siRNA may be coming from the pancreas itself as the down-regulation of Ca v b1 or b4 subunits, the b subunits that are not present in the pancreas [4, [29] [30] [31] [32] failed to reproduce this effect. Direct effect at the level of pancreas is further supported as glucose stimulation of (1) isolated islets from Ca v b2 or b3 siRNAinjected mice and (2) cultured pancreatic b-cells transfected with Ca v b2 or b3 siRNA led to increased insulin release (Fig. 2) .
Ca v b2-or b3siRNA-induced insulin release may be due to the activation of PKC isozymes (Fig. 3) . This may have come indirectly by the increased [Ca 2? ] i and IP3 levels with the down-regulation of Ca v b2 or b3 subunits as observed in the pancreatic b-cells of b3 -/-mice [29] . It is well known that these two intermediaries are the known activators of certain PKC isozymes [7, 33] . PKCs are known secretagogues for insulin even when [Ca 2? ] i in bcells is very low and they could substitute for Ca 2? as triggering signal for insulin release [2, 20] . In addition, PKC isozymes also mediate Ca 2? -stimulated insulin exocytosis [2] . Taken together, when present, Ca v b2 and b3 subunits negatively modulated [Ca 2? ] i , IP3 and PKC, leading to the inhibition of PKC isozymes and insulin secretion. The inhibition of PKC activity by the Ca v b3 subunits is known as increased neuronal function, a measure of PKC activation, was observed in Ca v b3 null mice [42] .
PKCs bII and h (in addition to PKCa) translocated to the membrane of pancreatic b-cells in this study as seen by others before [10] . However, the failure of PKC bII and h to modulate insulin secretion suggests that either one of these two isozymes per se is not sufficient for insulin secretion involving Ca v b subunits. On the contrary, PKCa, the predominant cPKC isozymes in the pancreatic b-cells [5, [8] [9] [10] decreased insulin and increased glucose levels upon its down-regulation in this study (Fig. 4) . This suggests that when present, PKCa isozyme may be involved in insulin secretion. Support for the role of PKCa in insulin release may be derived from the muscarinic cholinergic system, a well-known regulator of glucose-dependent insulin secretion [43, 44] . The muscarinic cholinergic system may release insulin through PKCa as acetyl-bmethylcholine (MCh), an agonist of muscarinic cholinergic receptor-activated PKCa [45] . PKCa isozyme may have targeted Ca v 1.0 family of channels as they are a good substrate for numerous protein kinases, such as protein kinase A, PKC, cGMP-dependent protein kinase, calcium/ calmodulin-dependent kinase II and protein tyrosine kinases [3, 40] .
Ca v b subunits are members of membrane-associated guanylate kinase family, thereby suggesting a role in scaffolding multiple signaling pathways around the channel. The tridimensional structure of this subunit supports the above statement as it has large space for the interaction with putative partners [40] ; PKCa may be one such partner. It was observed in our laboratory that Ca v b subunits inhibited the modulation of I Ca by MCh and phorbol 12-myristate 13-acetate (unpublished observation). It has been reported by others also that PKC responsiveness of the I Ca was modulated by Ca v b subunits in a Ca v a 1 subunitdependent manner [24, [46] [47] [48] [49] . Taken together, insulin secretion is the result of interaction between Ca v a 1 subunits, their Ser/Thr sites, Ca v b and PKC isozymes. The identification of the roles of these components will not only be significant for the understanding of the intricacies of the insulin secretion but also for the ion channel physiology.
